Yi-Zhou Jiang
Shanghai Medical College of Fudan University
ORCID: 0000-0002-0343-2955Also affiliated with Shenzhen University, Fudan University Shanghai Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial”.
Zhong-Hua Wang, Lin-Xiaoxi Ma, Song-Yang Wu, Jiong Wu, Ke-Da Yu +23 more
Qingyun Zou, Yi-Zhou Jiang, Jing Zheng, Chi Zhou
Uma Gaur, Zhibai Cao, Sheng‐Tao Hou, Wenhua Zheng, Yi-Zhou Jiang